Cover Image
Read Now

Drug class review on newer antiplatelet agents final report update 1

"The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug,...

Full description

Bibliographic Details
Main Author: Dailey, Janet H.
Corporate Authors: Oregon Health & Science University Evidence-based Practice Center, Southern California Evidence-Based Practice Center/RAND.
Format: eBook
Language:English
Published: Portland, Or. Oregon Health & Science University, Evidence-Based Practice Center c2007, 2007
Subjects:
Comparative Effectiveness Research
Drug Evaluation
United States
Platelet Aggregation Inhibitors / Therapeutic Use
Platelet Aggregation Inhibitors / Adverse Effects
Treatment Outcome
Vascular Diseases / Drug Therapy
Platelet Aggregation Inhibitors / Pharmacokinetics
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:"The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports."
Item Description:"April, 2007."
Physical Description:1 PDF file (91 p.) ill

Similar Items